La importancia de ampliar la reducción de daños a las personas que usan drogas no inyectadas

Noticias

La importancia de ampliar la reducción de daños a las personas que usan drogas no inyectadas

10 mayo 2013

Un enfoque de reducción de daños también debería incluir información fiable y objetiva sobre las diferentes sustancias que suelen consumirse a través de vías distintas de la inyección. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

By Brun González – Youth RISE IWG, Espolea Harm Reduction Program Coordinator

Harm reduction started as a response to the AIDS epidemic and the undeniable link it showed with a drug use through specific methods of consumption, and within a few specific populations (mainly heroin used intravenously and within people who use drugs, sex workers and men who have sex with men). This is why the strongest pillars of harm reduction services, practices and recommendations around the world focus mainly on condom distribution, opiate substitution treatment (methadone or buprenorphine) and needle and syringe exchange programs.

Although each of these areas of work are very important and to some extent go beyond their initial goals, for example condoms are useful to all people other than just heroin users or sex workers, and syringes and needles can be used to inject other drugs and not just heroin or opiates. However, many aspects of harm reduction ignore the majority of people who use drugs and who could really benefit from a harm reduction perspective for their own drug using situation and the impacts it has on their life.

These kind of harm reduction interventions include, besides the condoms and maybe sometimes the possibility to access clean and sterile injecting equipment, practical, friendly and objective information regarding different substances, both new and old, that are usually consumed via methods other than injecting.

Read here the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.